A new study conducted at the Women's College Research Institute of the University of Toronto is lending support to ovary removal in women with breast cancer who carry the BRCA1 genetic mutation. According to researcher Kelly Metcalfe, of the 676 women, carriers of the BRCA1 or BRCA2, who participated in the study, more than 77% survived over a 20 year follow-up, a 56% in breast cancer death following ovary removal.
Click here to read more about this study
No comments:
Post a Comment